2. QUALITATIVE AND QUANTITATIVE COMPOSITION
4.2 Dose and method of administration Dose (SPAF) Prevention of stroke, systemic embolism and reduction of vascular mortality in patients with atrial
Download 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
2014 AHA/ACC/HRS Atrial Fibrillation Guideline …
jaccjacc.cardiosource.com© American College of Cardiology Foundation and American Heart Association, Inc. 1 2014 AHA/ACC/HRS Atrial Fibrillation Guideline Data Supplements
COMPLICATIONS OF ATRIAL FIBRILLATION …
www.af-ablation.orgCatheter ablation complications. Introduction Currently, catheter ablation can be considered as an effective treatment among patients with symptomatic atrial fibrillation (AF), but both feasibility and safety of the procedure are strongly
CV CARLO PAPPONE MD FACC JAN-2010 - Af …
www.af-ablation.orgpage Curriculum Vitae Carlo Pappone, MD, PhD 3 3 Education MD Degree Oct. 29, 1986. School of Medicine, University of Naples Federico II. Thesis: “Effects of iloprost in the treatment
2016ESCGuidelinesforthemanagementofatrial ...
www.cardio.seESC GUIDELINES 2016ESCGuidelinesforthemanagementofatrial fibrillationdevelopedincollaborationwithEACTS The Task Force for the management of atrial fibrillation of the
2017 HOSPITAL OUTPATIENT PROCEDURES
www.medtronic.comPACEMAKER (PM) SYSTEM IMPLANTS o 33206 Insert new or replace perm PM w/atrial lead (J1) o 33207 Insert new or replace perm PM w/ventricular lead (J1)
New Treatment Guidelines in Atrial Fibrillation and ...
www.ucsfcme.com7/23/2015 1 New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs Dean Schillinger MD Professor of Medicine University of California, San Francisco